Infleqtion, Inc.
INFQ
$14.12
+12.51%
Infleqtion, Inc. is a technology company specializing in the development and commercialization of quantum technology products, including quantum sensing, quantum computing, and software, as part of a full-stack platform. The company operates in the emerging quantum technology industry, focusing on applications in defense, AI, energy, space, materials discovery, and cybersecurity. Infleqtion is a niche player in the quantum sector, distinct for its full-stack approach and early deployment in defense and other sectors. The current investor narrative is driven by significant government funding, including a $100 million grant, which has sparked a surge in the stock, but the company remains pre-revenue and loss-making, leading to debates about its speculative valuation and long-term viability.…
INFQ
Infleqtion, Inc.
$14.12
Related headlines
Investment Opinion: Should I buy INFQ Today?
Based on the analysis, INFQ is rated a Hold. The strong buy consensus and 60% upside to the average target of $20.60 are compelling, but the extreme valuation and fundamental losses temper enthusiasm. The thesis is that INFQ has significant growth potential driven by government support and early revenue, but the current price already reflects optimistic expectations, leaving limited margin of safety.
Sign up to view all
INFQ 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The company shows early revenue traction and strong analyst support, but the valuation is stretched and profitability is far off. The key factor is whether revenue can grow at a triple-digit rate to justify the premium. If Q2 revenue exceeds $15M and losses narrow, the stance would upgrade to bullish. Conversely, if revenue stagnates or cash burn accelerates, a downgrade to bearish is warranted.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Infleqtion, Inc.'s 12-month outlook, with a consensus price target around $20.60 and implied upside of +45.9% versus the current price.
Average Target
$20.60
0 analysts
Implied Upside
+45.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $22
Analyst target range
Analyst coverage is limited with only 5 analysts, but the consensus recommendation is 'strong buy' with a mean rating of 1.0. The average target price is $20.6, implying an upside of 60.2% from the current price of $12.86. The target range is $19.0 to $22.0, with the high target suggesting a 71.1% upside, reflecting expectations of significant growth and successful commercialization. The low target still implies a 47.7% upside, indicating that even the most bearish analyst sees value. The narrow spread between low and high targets (16%) suggests relatively high conviction among analysts, but the limited coverage and the company's speculative nature mean that price discovery may be inefficient, leading to higher volatility.
Bulls vs Bears: INFQ Investment Factors
Infleqtion presents a high-risk, high-reward speculative opportunity. The bull case is anchored by strong analyst conviction (60% upside), a $100M government grant, and the first revenue inflection, while the bear case highlights extreme valuation (122x sales), heavy losses, and liquidity risks. Currently, the bearish evidence is stronger due to the unsustainable valuation and lack of profitability, but the government backing and early revenue provide a credible path to growth. The central tension is whether INFQ can scale revenue fast enough to justify its premium valuation, or if the market will reprice the stock downward as losses persist. The outcome hinges on the pace of commercialization and the company's ability to convert its technological lead into sustainable revenue.
Bullish
- Strong Buy Consensus with 60% Upside: All 5 analysts rate INFQ a Strong Buy (mean rating 1.0), with an average target price of $20.60, implying a 60.2% upside from the current price of $12.86. Even the lowest target of $19.00 suggests a 47.7% gain, indicating high conviction in the company's growth trajectory.
- Government Grant Validates Technology: Infleqtion received a $100 million government grant, part of a $2 billion federal investment in quantum computing. This non-dilutive funding provides financial runway and validates the company's full-stack quantum platform, potentially accelerating commercialization in defense and other sectors.
- Revenue Inflection Point Achieved: Q1 2026 revenue surged to $9.461 million from zero in the prior three quarters, marking the company's first meaningful sales. This inflection suggests early commercial traction, with analysts projecting full-year revenue of $69.4 million, a 7.3x increase from the current quarterly run rate.
- Strong Cash Position Post-Financing: Infleqtion raised $525.6 million in Q1 2026, boosting cash to $84.874 million. With zero debt (debt-to-equity ratio of 0), the company has ample liquidity to fund R&D and operations for several years, reducing near-term bankruptcy risk despite negative cash flow.
Bearish
- Extreme Valuation at 122x Sales: With a trailing price-to-sales ratio of 122.5x and EV/Sales of 67.2x, INFQ trades at a massive premium even for a growth stock. This implies the market expects near-perfect execution and rapid revenue scaling; any miss could trigger a severe de-rating.
- Heavy Losses and Negative Margins: Q1 2026 net loss was -$30.263 million with a net margin of -319.9%. Operating income was -$33.575 million, and EBITDA was -$29.315 million, reflecting significant ongoing investment in R&D ($9.951M) and G&A ($26.32M) with minimal revenue to offset costs.
- Liquidity Concerns with Current Ratio 0.014: The current ratio of 0.014 indicates that current liabilities far exceed current assets, suggesting potential short-term solvency issues. Although the company raised $525.6M in Q1, the cash balance of $84.874M may be insufficient if losses continue at the current burn rate.
- Stock Down 17.5% Since Listing: INFQ has declined from its IPO price of $15.59 to $12.86, a 17.5% drop, and is trading near the lower end of its 52-week range (60.4% of the range). Market cap has shrunk from $2.18B to $866M, reflecting waning investor confidence and a potential falling knife.
INFQ Technical Analysis
Infleqtion's stock has exhibited a volatile and predominantly downward trend since its listing in February 2026. The 1-year price change is not available as the stock has been trading for only six months, but from its listing price of $15.59, the current price of $12.86 represents a decline of approximately 17.5%. The stock is currently trading at 60.4% of its 52-week range (between $8.52 and $21.28), indicating it is closer to the lower end, which suggests a bearish sentiment and potential value opportunity or falling knife scenario. The stock's market cap has also shrunk from $2.18 billion at listing to $866 million, reflecting a significant loss in investor confidence.
Beta
—
—
Max Drawdown
-55.6%
Largest decline past year
52-Week Range
$9-$21
Price range past year
Annual Return
—
Cumulative gain past year
| Period | INFQ Return | S&P 500 |
|---|---|---|
| 1m | +37.9% | +2.5% |
| 3m | -13.6% | +2.7% |
| 6m | +6.2% | +11.1% |
| 1y | — | +20.5% |
| ytd | — | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
INFQ Fundamental Analysis
Infleqtion's revenue trajectory is nascent, with the most recent quarter (Q1 2026) reporting revenue of $9.461 million, a significant increase from zero revenue in the prior three quarters, but still minimal for a company with a market cap of $866 million. The company's net income for Q1 2026 was -$30.263 million, with a net margin of -319.9%, indicating heavy losses. Gross margin was 21.0%, which is low for a technology company, but the company is investing heavily in R&D ($9.951 million) and G&A ($26.32 million) to build its platform. The company is unprofitable, with a trailing twelve-month free cash flow of -$21.744 million, and its balance sheet shows a current ratio of 0.014, indicating potential liquidity issues, though it raised $525.6 million in financing in Q1 2026, providing a cash buffer of $84.874 million. The debt-to-equity ratio is 0, suggesting no debt, but the company's negative ROE of -19.3% reflects its loss-making status.
Quarterly Revenue
$9461000.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
21.0%
Latest Quarter
Free Cash Flow
$-21743729.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is INFQ Overvalued?
Given that Infleqtion has negative net income, the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 122.5x (based on historical data), but the forward PS ratio is not directly provided; however, using the estimated revenue of $69.4 million for the next year, the forward PS would be approximately 12.5x, indicating a significant premium. The EV/Sales ratio is 67.2x, which is extremely high, reflecting the market's expectation of rapid growth. Compared to the industry average, which is not provided, but given the speculative nature of quantum stocks, this premium may be justified by the potential for disruptive technology and government support. Historically, the PS ratio has ranged from 0 to 122.5x, and the current level is near the high end, suggesting the market is pricing in optimistic growth expectations.
PE
-12.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-12.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The company is deeply unprofitable, with a Q1 2026 net loss of -$30.263 million and a net margin of -319.9%. The negative free cash flow of -$21.744 million (TTM) indicates ongoing cash burn, though the $525.6 million raised in Q1 provides a buffer. However, the current ratio of 0.014 is alarmingly low, suggesting that current liabilities are 71x current assets, which could lead to liquidity stress if additional funding is not secured. The company's reliance on government grants and future financing makes it vulnerable to funding disruptions, and the high G&A expenses ($26.32M) relative to revenue ($9.461M) indicate inefficiencies that may persist.